Skip to main
HTFL

HeartFlow Inc (HTFL) Stock Forecast & Price Target

HeartFlow Inc (HTFL) Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 33%
Buy 44%
Hold 22%
Sell 0%
Strong Sell 0%

Bulls say

HeartFlow is a commercial-stage medical technology company with a strong and growing product portfolio, including three software products that have potential for continued development and expansion. The company operates in a large and still underpenetrated market, with a robust margin outlook and potential for both revenue upside and expansion into new markets through AI-powered software capabilities. While there are some potential risks to our target price, including competition and reimbursement changes, we maintain a positive outlook on HeartFlow's stock based on their strong Q2 results, solid business momentum, and potential for future growth and profitability.

Bears say

HeartFlow is experiencing significant growth in both its plaque and FFRCT businesses, with overall revenues beating analysts' projections and gross margins reaching a new high. The synergies between these two segments also bode well for future margin expansion. However, the company's continued increase in revenue guidance for 2026 raises concerns about potential overvaluation and the potential for future market saturation.

HeartFlow Inc (HTFL) has been analyzed by 9 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 44% recommend Buy, 22% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of HeartFlow Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About HeartFlow Inc (HTFL) Forecast

Analysts have given HeartFlow Inc (HTFL) a Buy based on their latest research and market trends.

According to 9 analysts, HeartFlow Inc (HTFL) has a Buy consensus rating as of Sep 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $42.78, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $42.78, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

HeartFlow Inc (HTFL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.